KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Operating Expenses (2016 - 2025)

Stereotaxis (STXS) has disclosed Operating Expenses for 16 consecutive years, with $10.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 2.05% to $10.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.0 million, a 9.63% increase, with the full-year FY2024 number at $39.3 million, up 7.18% from a year prior.
  • Operating Expenses was $10.7 million for Q3 2025 at Stereotaxis, up from $8.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $10.8 million in Q4 2024 to a low of $7.5 million in Q1 2021.
  • A 5-year average of $9.4 million and a median of $9.5 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 60.51% in 2021, then decreased 8.34% in 2025.
  • Stereotaxis' Operating Expenses stood at $9.3 million in 2021, then dropped by 5.74% to $8.8 million in 2022, then dropped by 8.25% to $8.0 million in 2023, then soared by 34.83% to $10.8 million in 2024, then fell by 1.71% to $10.7 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Operating Expenses are $10.7 million (Q3 2025), $8.6 million (Q2 2025), and $10.0 million (Q1 2025).